KRAS and non-small cell lung carcinoma: KRAS&lt;sup&gt;G12C&lt;/sup&gt; inhibitors versus chemotherapy alone for KRAS&lt;sup&gt;G12C&lt;/sup&gt;-mutated non-small cell lung cancer: a pooled analysis of CodeBreaK 200 and KRYSTAL-12 trials.